12:00 AM
 | 
Apr 17, 1995
 |  BC Week In Review  |  Clinical News  |  Regulatory

Andrulis Pharmaceuticals Corp. regulatory update

The Beltsville, Md., company received U.S. Patent No. 5,405,855 covering the use...

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >